Evidence map›Paper›PMID 24939454›Full record

ArticleBMJ case reports2014

Focal and abnormally persistent paralysis associated with congenital paramyotonia.

Armelle Magot, Albert David, Damien Sternberg, Yann Péréon

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Armelle MagotCentre de Référence Maladies Neuromusculaires Nantes-Angers, Nantes, France.
Albert DavidService de génétique médicale, Nantes, France.
Damien SternbergCentre de Référence des Canalopathies Musculaires, Service de Biochimie Métabolique, ICM UMR_S975, Paris, France.
Yann PéréonCentre de Référence Maladies Neuromusculaires Nantes-Angers, Nantes, France.
Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers · FRGénétique Médicale & Génomique Fonctionelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations of the skeletal muscle voltage-gated sodium channel (NaV1.4) are an established cause of several clinically distinct forms of periodic paralysis and myotonia. Focal paresis has sometimes already been described. We report a case with atypical clinical manifestation comprising paramyotonia and cold-induced persistent and focal paralysis. A 27-year-old woman presented with paramyotonia congenita since her childhood. She experienced during her childhood one brief episode of generalised weakness. At the age of 27, she experienced a focal paresis lasting for several months. The known mutation p.Val1293Ile was found in the muscle sodium channel gene (SCN4A). Channel inactivation is involved in most Na(+) channelopathies. Fast inactivation is known to be responsible for the myotonia phenotype. We hypothesise that the V1293I mutation may also alter the slow inactivation in specific conditions, for example, prolonged cold exposure or prolonged and intensive exercise. This observation broadens the spectrum of clinical manifestations of this sodium channel mutation.

Indexed as

FemaleHumansMexiletineMutationMyotonia CongenitaNAV1.4 Voltage-Gated Sodium ChannelParalysisTreatment OutcomeVoltage-Gated Sodium Channel BlockersYoung AdultMexiletineNAV1.4 Voltage-Gated Sodium ChannelVoltage-Gated Sodium Channel Blockers

Identifiers

PMID24939454
PMCPMC4069699
OpenAlexW2327729319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.